Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VA/DoD GERD guideline (correction)

Executive Summary

Veteran's Affairs/Department of Defense draft guideline states both proton pump inhibitors and H2-antagonists can be used for initial treatment of gastroesophageal reflux disease. "The Pink Sheet" (1April 21, p. 15) incorrectly suggested that the guidelines consider the two drug classes to be equally effective. Both Johnson & Johnson/Eisai's Aciphex (rabeprazole) and TAP's Prevacid (lansoprazole) are included on the Basic Core Formulary...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS041716

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel